KRT8 and in situ carcinoma: The majority of mammary tumors (invasive and in situ carcinoma, and benign proliferations) from p53fl/fl;KrasG12D;myr-p110αfl/fl mice displayed strong CK8, ERα and PR immunostaining (Figure 4b).